Company Info
Phone(858) 794-8889
Year Established
1999
Ticker
HALO
Exchange
NASDAQ
Contacts
Helen Torley , M.B. Ch. B., M.R.C.P.President & CEO
Paul Spence
CCO
Mark Snyder
General Counsel
Nicole LaBrosse
CFO
Charles Theuer, MD, Ph.D.
CMO
Chris Wahl, MD, MBA
CSO
Company Description
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies that target the tumor microenvironment.